SAURABH BHAN: Open Payments
NPI 1164497715 · KALAMAZOO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$568 in 13 payments from 12 companies in 2025. Trend: 2023 $32 · 2024 $575 · 2025 $568
Food & beverage: $568
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $118 |
| TG Therapeutics, Inc. | 1 | $116 |
| EMD Serono, Inc. | 2 | $92 |
| Vanda Pharmaceuticals Inc. | 1 | $71 |
| Alexion Pharmaceuticals, Inc. | 1 | $31 |
| SK Life Science, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $22 |
| GENZYME CORPORATION | 1 | $20 |
| UCB, Inc. | 1 | $20 |
| Cycle Pharmaceuticals Inc | 1 | $18 |
Products named: BRIUMVI, PONVORY, Mavenclad, ULTOMIRIS, XCOPRI, KISUNLA, Nayzilam, Bafiertam.
Industry payments across MI — which companies pay providers there.
